Acquisition

graphic of a larger shark chomping up a smaller one
Biotech

Novartis pays $2B for breast cancer program as rivals circle

Novartis is paying Synnovation $2 billion upfront for an asset that could defend its breast cancer franchise from challengers including Eli Lilly.
Nick Paul Taylor Mar 20, 2026 5:19am
Servier
Favicon Fierce Pharma

Servier rounds out rare cancer offerings with $2.5B Day One buy

Mar 6, 2026 10:14am
Axis Powers

Asahi Kasei to buy Germany's Aicuris for $920M

Feb 26, 2026 2:00am
more expensive

China is no longer licensing 'bargain basement': analyst

Feb 24, 2026 5:07pm
MA

4 trends driving biopharma M&A this year, per Bain

Jan 28, 2026 5:00pm
Graphic of two hands shaking under a red and purple light

WEP Clinical widens reach with European CRO buy

Jan 7, 2026 2:55pm